Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DYN
ELVN
Add up to 3 more stocks
DYN
Dyne Therapeutics, Inc.
-0.26%
$15.40-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.88B
52W Range
$12.77 - $27.31
ELVN
Enliven Therapeutics, Inc.
-6.77%
$42.39-3.08Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.03B
52W Range
$14.79 - $62.32
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.10 | 3.38 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -74.0% | -11.8% |
| ROA | -52.3% | -11.6% |
| ROIC | -58.3% | -13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.02 | 64.07 |
| Quick Ratio | 12.02 | 64.07 |
| Debt/Equity | 0.03 | 0.00 |
| Interest Coverage | -75.61 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.